General MedicationsINJECTIONStandard

KETOROLAC TROMETHAMINE

Standard Dose

60MG/2ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview KETOROLAC TROMETHAMINE is listed in Drugs@FDA under application 076722 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient KETOROLAC TROMETHAMINE Form and strength INJECTABLE; INJECTION - 60MG/2ML Sponsor GLAND PHARMA LTD Submission history Latest submission status date: 2016-05-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview KETOROLAC TROMETHAMINE is listed in Drugs@FDA under application 076722 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient KETOROLAC TROMETHAMINE Form and strength INJECTABLE; INJECTION - 60MG/2ML Sponsor GLAND PHARMA LTD Submission history Latest submission status date: 2016-05-09 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.